In a groundbreaking move, the Centers for Medicare and Medicaid Services (CMS) announced potential savings of up to $685 million for over 55 million Medicare Part D enrollees. This initiative, part of ...

Medicare’s 2026 drug price negotiations under the Inflation Reduction Act aim to lower the cost of expensive medications, ...

The IRA requires health plans serving the Part D market to cover all negotiated drugs, and it has been predicted that CMS ...

Medicare prescription drug costs are entering a new phase in 2026, and for millions of beneficiaries the changes could ...

The pharma industry has called the IRA “price setting” and argues that the negotiations have not cut out-of-pocket costs for ...

The Centers for Medicare and Medicaid Services has announced the expected savings from a second round of Medicare drug price negotiations. There is a net savings of 44%, or $12 billion, from ...

Medicare has completed its second round of price negotiations for 15 top-selling prescription drugs and posted maximum fair prices, per an Inflation Reduction Act provision. The announced net prices, ...

(CNN) — Medicare will save approximately $12 billion, or 44%, on 15 high-cost medications as a result of the second round of the program’s drug price negotiations, the Trump administration announced ...

Medicare will save approximately $12 billion, or 44%, on 15 high-cost medications as a result of the second round of the program's drug price negotiations, the Trump administration announced Tuesday ...